Deals

You are here: Home : Topics A-Z : Deals

Deal With It

Banks aren't lending, investor defaults are looming, and mark-to-market is a pain. But private equity CFOs are forging a path through the downturn.

April 2, 2009

What's in a name? When the name in question is SuperReturn International, an annual conference for private equity professionals, the answer is a lot of hubris and even more irony. A celebratory affair when private equity players were helping to fuel an M&A boom, February's SuperReturn International raised questions about whether its name was still suitable given that private equity returns across Europe fell 25% in 2008. Read more...

Follow this topic

Sign up for newsletters
Subscribe to our Deals RSS feed

More Deals Articles

Deals: There Will Be Oil ... in Calgary, Anyway
In our M&A Roundup for the week ended March 29, Suncor's $18.39-billion purchase of Petro-Canada tops the sale of Calgary-based Oilexco's North Sea assets. Deloitte, Time Warner also do some buying. March 30, 2009
Deals: Fertilizer, Roller Coasters, and Gold
In our M&A Roundup for the week ended March 22, a diverse lot of billion-dollar deals helps keep the totals respectable — though far short of the prior "Merck Week." March 23, 2009
Deals: Pharma Is the Cure for M&A's Blahs
In our M&A Roundup for the week ended March 15, Merck-Schering is followed — at a distance — by Gilead Sciences buying CV Therapeutics. Behind them, an eclectic mix. March 16, 2009
Deals: A Copy Cat Play with Merck in Wings
In our M&A Roundup for the week ended March 8, another solid combination of resources, energy, and pharma deals — on the eve of today's Schering-Plough announcement. March 9, 2009
Deals: They Resurface in a Global Flurry
In our M&A Roundup for the week ended March 1, values surge from the prior week, and every North American transaction but one is cross-border. March 2, 2009
Deals: Where Have All the Mergers Gone?
In our M&A Roundup for the week ended Feb. 22, no big deal emerges to keep weekly totals respectable, as has been the case during the general fall-off in transactions the last few months. February 23, 2009
Deals: A Week of Health and Energy
In our M&A Roundup for the week ended Feb. 15, power-related companies and firms with medical connections account for most transactions. But none tops $1 billion. February 17, 2009
Deals: High on Drugs
In our M&A roundup for the final week of January, two huge drug company acquisitions pep up merger activity in an otherwise dreary month. February 3, 2009
Deals: Mid-sized M&A Rules the Week
In our M&A Roundup for the week ending Jan. 25, while Pfizer-Wyeth was being nailed down quietly, only smaller transactions took shape, led by a $584m combination of software companies Autonomy Corp. and Interwoven Inc. January 26, 2009